Plain-English translation of NCT06147037 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new radioactive cancer treatment called in people with advanced solid tumors. The study has two parts: first, researchers will find the right dose of a preparation medicine to give before the main treatment, and then they will test increasing doses of the radioactive medication itself to determine the safest and most effective dose.
Many people with advanced cancers have exhausted standard treatment options or cannot tolerate them. This trial explores whether this new radioactive treatment approach can help control cancer in these difficult-to-treat situations.
You likely qualify if…
You likely don't qualify if…
You will be part of either the first group (finding the right preparation dose) or the second group (testing increasing doses of the main treatment). You will receive the preparation medicine and then the radioactive treatment, along with imaging scans to monitor how your body responds and how the medication is working. The study will involve multiple visits to the trial center for treatment administration, blood tests, and imaging procedures to track both safety and how well the treatment is working against your cancer.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States